Latest Insider Transactions at Principia Biopharma Inc. (PRNB)
This section provides a real-time view of insider transactions for Principia Biopharma Inc. (PRNB). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Principia Biopharma Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Principia Biopharma Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 18
2019
|
Glaxosmithkline PLC |
BUY
Open market or private purchase
|
Indirect |
357,142
+10.69%
|
$9,999,976
$28.0 P/Share
|
|
May 21
2019
|
Orbimed Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,000,000
-38.38%
|
$30,000,000
$30.25 P/Share
|
|
Sep 18
2018
|
Orbimed Advisors LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
250,000
+8.75%
|
$4,250,000
$17.0 P/Share
|
|
Sep 18
2018
|
Orbimed Advisors LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
2,355,713
+21.73%
|
-
|
|
Sep 18
2018
|
Glaxosmithkline PLC |
BUY
Open market or private purchase
|
Indirect |
270,000
+9.32%
|
$4,590,000
$17.0 P/Share
|
|
Sep 18
2018
|
Glaxosmithkline PLC |
BUY
Conversion of derivative security
|
Indirect |
2,355,713
+21.73%
|
-
|